 |
Depósito mínimo $50 Promoção exclusiva |
Nossa pontuação |
0% comissão |
Are you looking to buy ACADIA Pharmaceuticals stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NASDAQ:ACAD! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about ACADIA Pharmaceuticals stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. It is also developing pimavanserin as a treatment for dementia-related psychosis and as an adjunctive treatment for schizophrenia that are in Phase III clinical trials; and pimavanserin as an adjunctive treatment for major depressive disorder. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Volume médio
947,279 shs
MERCADO CAP
$8.28 billion
Bolsa de Valores
NASDAQ
Comprem essas ações!
|
NOME
|
TICKER
|
INDÚSTRIA
|
SECTOR
|
VOLUME
|
COMPRAR AGORA ESSAS AÇÕES
|
|---|---|---|---|---|---|
|
NASDAQ: ACAD
|
Preparações farmacêuticas
|
Médico
|
3,794 shs
|
Below is a quick guide on how to buy NASDAQ:ACAD stocks safe, fast and around the world in less than five minutes.
Passo 1: Abrir uma conta no eToro – eToro is the best broker to buy ACADIA Pharmaceuticals shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Passo 2: Carregue sua identificação - Conforme os regulamentos da KYC, eToro lhe pedirá que carregue uma cópia de seu passaporte ou de sua carteira de motorista.
Etapa 3: Fundos de depósito - Deposite algum dinheiro em sua recém-criada conta eToro. O senhor pode escolher entre transferência bancária, carteira eletrônica, cartão de débito/crédito ou Paypal.
Passo 4: Buy ACADIA Pharmaceuticals – Search for “”NASDAQ:ACAD”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought ACADIA Pharmaceuticals stocks with 0% commission!.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
16 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for ACADIA Pharmaceuticals in the last twelve months. There are currently 1 hold rating, 14 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” ACADIA Pharmaceuticals stock.
Wall Street analysts have given ACADIA Pharmaceuticals a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but ACADIA Pharmaceuticals wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
2 |  | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
3 |  | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NASDAQ:ACAD stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy ACADIA Pharmaceuticals stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy ACADIA Pharmaceuticals stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Como o eToro é uma plataforma regulamentada, o senhor precisará completar o processo KYC, isso é uma prática padrão e leva apenas alguns minutos. O senhor precisará fornecer um documento de identificação com foto (passaporte, carteira de motorista) e comprovante de endereço (conta de serviços públicos, extrato bancário).
Uma vez que o senhor tenha se inscrito e verificado sua conta, precisará depositar fundos. eToro aceita cartões de crédito/débito, transferências bancárias, e também carteiras eletrônicas. Portanto, qualquer que seja sua preferência, haverá algo para o senhor.
Now that you’ve funded your eToro account, just type “NASDAQ:ACAD stocks” na barra de busca na parte superior da tela e pressione "trade".
All that’s left is to buy some NASDAQ:ACAD stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NASDAQ:ACAD is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy ACADIA Pharmaceuticals stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
ACADIA Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Wednesday, February 24th 2021.
View our earnings forecast for ACADIA Pharmaceuticals.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) announced its quarterly earnings results on Monday, November, 9th. The biopharmaceutical company reported ($0.54) earnings per share for the quarter, missing the consensus estimate of ($0.38) by $0.16. The biopharmaceutical company earned $120.58 million during the quarter, compared to the consensus estimate of $118.82 million. ACADIA Pharmaceuticals had a negative trailing twelve-month return on equity of 40.35% and a negative net margin of 63.92%. The firm’s revenue for the quarter was up 27.5% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.29) earnings per share.
View ACADIA Pharmaceuticals’ earnings history.
ACADIA Pharmaceuticals’ stock was trading at $36.87 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ACAD shares have increased by 42.3% and is now trading at $52.46.
16 brokers have issued twelve-month price targets for ACADIA Pharmaceuticals’ stock. Their forecasts range from $42.00 to $72.00. On average, they anticipate ACADIA Pharmaceuticals’ share price to reach $61.25 in the next year. This suggests a possible upside of 16.8% from the stock’s current price.
View analysts’ price targets for ACADIA Pharmaceuticals or view top-rated stocks among Wall Street analysts.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NASDAQ:ACAD stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Mais de 95% de fundos de clientes são mantidos offline, em câmara fria, o que é crucial para qualquer corretor que administre seus ativos. Independentemente de quão segura deve ser uma plataforma, recomendamos o uso do 2FA para acrescentar uma camada adicional de segurança à sua conta.
eToro oferece aos usuários uma gama de recursos para começar a investir o mais rapidamente possível. Eles têm uma característica relativamente única chamada negociação de cópias, que lhe permite ganhar uma renda passiva ao espelhar comerciantes experientes, o que lhe permite começar a ter lucro rapidamente, e lhe dá uma melhor compreensão das estratégias usadas pelos profissionais. Além disso, o eToro permite aos usuários investir em carteiras administradas, sendo uma carteira administrada uma variedade de ativos semelhantes agrupados, permitindo ao senhor diversificar sua conta, reduzindo qualquer risco potencial. Para aqueles com experiência anterior em negociação, o senhor pode investir em mercados fora das ações, já que eToro permite aos usuários negociar ETFs, commodities, criptografia e índices. Se o senhor já investir fora do espaço da bolsa de valores, isso pode ser muito útil, pois permite ao senhor administrar todos os seus investimentos em um só lugar.
ACADIA Pharmaceuticals’ management team includes the following people:
Mr. Stephen R. Davis, CEO & Director (Age 60, Pay $1.36M)
Dr. Srdjan R. Stankovic, Pres (Age 64, Pay $1.23M)
Ms. Elena H. Ridloff C.F.A., CFA, Exec. VP & CFO (Age 41, Pay $689.09k)
Mr. Austin D. Kim, Exec. VP, Gen. Counsel & Sec. (Age 57, Pay $700.8k)
Mr. Michael J. Yang, Exec. VP & Chief Commercial Officer (Age 59, Pay $810.41k)
Mr. James K. Kihara, VP, Corp. Controller & Principal Accounting Officer (Age 41)
Mr. Bob Mischler, Sr. VP of Strategy & Technology Operations
Dr. Eliseo Oreste Salinas, Sr. VP, Chief Scientific Officer & Head of External Innovation (Age 65)
Mr. Mark C. Johnson, VP of Investor Relations
Ms. Stephanie Fagan, Sr. VP of Corp. Affairs & Chief Communications Officer
8 employees have rated ACADIA Pharmaceuticals CEO Steve Davis on Glassdoor.com. Steve Davis has an approval rating of 88% among ACADIA Pharmaceuticals’ employees.
Os CFDs são instrumentos complexos e vêm com um alto risco de perder dinheiro rapidamente devido à alavancagem. 68% de contas de investidores de varejo perdem dinheiro ao negociar CFDs com esse provedor. O senhor deve considerar se compreende como os CFDs funcionam, e se pode arcar com o alto risco de perder seu dinheiro.
Some companies that are related to ACADIA Pharmaceuticals include Astellas Pharma (ALPMY), Shiseido (SSDOY), Takeda Pharmaceutical (TKPYY), Genmab A/S (GMAB), Genmab A/S (GNMSF), MERCK Kommanditgesellschaft auf Aktien (MKGAF), CureVac (CVAC), UCB (UCBJF), Catalent (CTLT), Alnylam Pharmaceuticals (ALNY), Horizon Therapeutics Public (HZNP), Royalty Pharma (RPRX), BioMarin Pharmaceutical (BMRN), Ono Pharmaceutical (OPHLF) and Elanco Animal Health (ELAN).
View all of ACAD’s competitors.
Based on aggregate information from Reportlab watchlists, some companies that other ACADIA Pharmaceuticals investors own include Micron Technology (MU), NVIDIA (NVDA), Gilead Sciences (GILD), Sarepta Therapeutics (SRPT), Pfizer (PFE), Tesla (TSLA), Alibaba Group (BABA), Amarin (AMRN), Advanced Micro Devices (AMD) and Exelixis (EXEL).
ACADIA Pharmaceuticals trades on the NASDAQ under the ticker symbol “ACAD.”
ACADIA Pharmaceuticals’ stock is owned by a number of institutional and retail investors. Top institutional investors include FMR LLC (12.25%), BlackRock Inc. (4.55%), First Trust Advisors LP (1.02%), Frontier Capital Management Co. LLC (0.60%), Jennison Associates LLC (0.37%) and Candriam Luxembourg S.C.A. (0.19%). Company insiders that own ACADIA Pharmaceuticals stock include Austin D Kim, Bros Advisors Lp Baker, Elena Ridloff, Eric Alejandro Miller, James M Daly, Laura Brege, Michael J Yang, Srdjan R Stankovic and Stephen Davis.
View institutional ownership trends for ACADIA Pharmaceuticals.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
ACAD stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, First Trust Advisors LP, Frontier Capital Management Co. LLC, First Midwest Bank Trust Division, Riggs Asset Managment Co. Inc., Peregrine Capital Management LLC, Candriam Luxembourg S.C.A., and Profit Investment Management LLC. Company insiders that have sold ACADIA Pharmaceuticals company stock in the last year include Austin D Kim, Elena Ridloff, James M Daly, Michael J Yang, Srdjan R Stankovic, and Stephen Davis.
View insider buying and selling activity for ACADIA Pharmaceuticals or view top insider-selling stocks.
ACAD stock was bought by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Cardan Capital Partners LLC, BlackRock Inc., DNB Asset Management AS, Russell Investments Group Ltd., TCW Group Inc., Nisa Investment Advisors LLC, and Aperio Group LLC.
View insider buying and selling activity for ACADIA Pharmaceuticals or or view top insider-buying stocks.
Shares of ACAD can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Revisão dos Corretores Interativos, Revisão eToro, Revisão DEGiro, Revisão da AvaTrade, IG Markets Review, Revisão dos Mercados de IC, CMC Markets Review, Admiral Markets Review e muitos mais. Leia uma das revisões para saber tudo sobre o corretor e comece agora a comprar ações.
One share of ACAD stock can currently be purchased for approximately $52.46.
ACADIA Pharmaceuticals has a market capitalization of $8.34 billion and generates $339.08 million in revenue each year. The biopharmaceutical company earns $-235,260,000.00 in net income (profit) each year or ($1.60) on an earnings per share basis.
ACADIA Pharmaceuticals employs 580 workers across the globe.
No Reportlab.org queremos garantir que o senhor tenha todas as informações mais relevantes sobre compra de ações. Trazemos-lhe os melhores guias sobre o mercado de ações, com revisões pessoais, informações de base, revisões de plataforma, como fazer e muito mais. Deseja obter outras informações? Então confira os Ações OTC, Ações da NASDAQ, Ações da NYSE, Ações LONES, Ações de FRA, Ações ETR, Ações da APE, Ações TSX ou Ações Amex. Procurando informações mais detalhadas como Ações de 5g, ações biotecnológicas, estoques de ouro e outras informações de nosso reportlab.
How can you buy ACADIA Pharmaceuticals stock on the internet?
You can easily buy ACADIA Pharmaceuticals stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Outra opção é usar um corretor regulamentado como Mercados de IC ou Corretores Interativos. You can an account with these brokers and start buying or trading NASDAQ:ACAD stocks in a safe and complete environment to trade in.
Where to buy ACADIA Pharmaceuticals stock?
You will first want to find a licensed broker that supports NASDAQ:ACAD stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NASDAQ:ACAD stocks in a safe and complete environment.
Is NASDAQ:ACAD stock a good investment?
As with any other asset, there is an element of risk associated with buying NASDAQ:ACAD stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is ACADIA Pharmaceuticals stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NASDAQ:ACAD is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in ACADIA Pharmaceuticals stock.
How do you trade ACADIA Pharmaceuticals stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for ACADIA Pharmaceuticals stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NASDAQ:ACAD stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell ACADIA Pharmaceuticals stock?
To sell your NASDAQ:ACAD stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best ACADIA Pharmaceuticals stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NASDAQ:ACAD stock.
Stephen sabe muito sobre produtos financeiros e, em particular, tem uma grande paixão pelas bolsas de valores e por seus participantes. Esperamos que a informação fornecida ajude o senhor. Algo não está muito claro? Queira deixar suas perguntas ou comentários no final da página.
| Nossa pontuação ★★★★★ | |
| Nossa pontuação ★★★★★ | |
| Nossa pontuação ★★★★★ |
Boletim informativo
Notícias recentes
| |
Nossa pontuação |
0% comissão |
Ações em tempo real e dados criptográficos
Notificações, Dicas e Notícias
Melhores Ações e Guias Criptográficos
Corretor Online & Câmbio de Revisões
Reportlab Finanças é puramente um website informativo e em nenhum caso implica aconselhamento sobre investimentos. Todos os investimentos comportam riscos e o senhor pode perder todos os seus investimentos. Não invista dinheiro que o senhor não pode perder.
Reportlab Finanças
38 Holburn Lane
Heckfield Green
IP21 0UB
Reino Unido
Copyright © 2022 Reportlab.Finance | Todos os direitos reservados.
